(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -15.68%9.73M | 26.48%30.82M | 26.55%11.54M | 75.01%24.37M | 108.19%9.12M | 271.28%13.92M | 213.17%4.38M | -86.31%3.75M | -132.79%-3.87M | -2.01%27.4M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -53.85%-1.1M | -61.85%-1.87M | -112.17%-715K | -9.89%-1.16M | 47.01%-337K | -1,152.38%-1.05M | -1,100.00%-636K | -42.37%-84K | -65.63%-53K | 60.14%-59K |
Attributable subsidiary (profit) loss | --1.35M | --1.37M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | 225.96%262K | 116.34%834K | 90.74%-208K | -4,352.50%-5.1M | -351.00%-2.25M | -96.37%120K | -137.58%-498K | 2,703.39%3.31M | 1,877.61%1.33M | -75.16%118K |
-Impairmen of inventory (reversal) | 311.45%351K | 120.40%983K | 91.57%-166K | -1,391.96%-4.82M | -312.79%-1.97M | -85.06%373K | -186.57%-477K | 694.90%2.5M | 218.50%551K | 17.60%314K |
-Impairment of trade receivables (reversal) | -111.90%-89K | 47.54%-149K | 84.84%-42K | -12.25%-284K | -1,219.05%-277K | -131.16%-253K | -102.71%-21K | 514.29%812K | 830.19%774K | -194.23%-196K |
Revaluation surplus: | -900.00%-440K | -7.11%771K | -6.78%55K | 764.58%830K | -7.81%59K | 209.09%96K | --64K | ---88K | ---- | ---- |
-Other fair value changes | -900.00%-440K | -7.11%771K | -6.78%55K | 764.58%830K | -7.81%59K | 209.09%96K | --64K | ---88K | ---- | ---- |
Asset sale loss (gain): | ---76K | -97.94%2K | ---- | 646.15%97K | -8.33%-13K | 127.66%13K | ---12K | 69.48%-47K | ---- | 12.00%-154K |
-Loss (gain) on sale of property, machinery and equipment | ---76K | --2K | ---- | ---- | -92.31%1K | 127.66%13K | --13K | 69.48%-47K | ---- | -65.59%-154K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | --97K | 44.00%-14K | ---- | ---25K | ---- | ---- | ---- |
Depreciation and amortization: | 12.14%1.43M | 8.15%2.63M | 14.22%1.28M | 29.46%2.43M | 30.15%1.12M | 8.00%1.88M | -6.43%859K | 9.31%1.74M | 18.30%918K | 27.92%1.59M |
-Depreciation | 12.95%1.26M | 8.80%2.29M | 15.71%1.11M | 13.61%2.1M | 11.87%961K | 6.50%1.85M | -6.43%859K | 9.31%1.74M | 18.30%918K | 27.92%1.59M |
-Other depreciation and amortization | 6.67%176K | 3.98%340K | 5.10%165K | 1,157.69%327K | --157K | --26K | ---- | ---- | ---- | ---- |
Financial expense | 24.14%36K | -21.95%64K | -19.44%29K | 30.16%82K | 44.00%36K | -26.74%63K | -37.50%25K | -67.05%86K | -78.14%40K | 75.17%261K |
Exchange Loss (gain) | 1,691.30%366K | -185.19%-115K | -152.27%-23K | -23.73%135K | 104.11%44K | 255.26%177K | -5,731.58%-1.07M | -275.38%-114K | 135.85%19K | -83.91%65K |
Special items | ---- | ---- | ---- | 13,300.00%264K | ---- | ---2K | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | -3.28%11.57M | 57.24%34.51M | 53.66%11.96M | 44.24%21.95M | 149.98%7.78M | 77.97%15.22M | 291.92%3.11M | -70.74%8.55M | -112.80%-1.62M | -2.57%29.22M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -49.92%927K | 112.51%2.53M | 113.14%1.85M | -305.00%-20.2M | -247.33%-14.09M | 129.56%9.86M | -209.38%-4.06M | 408.63%4.29M | 207.60%3.71M | -3,874.29%-1.39M |
Accounts receivable (increase)decrease | -16.00%2.32M | -84.53%1.45M | 165.54%2.76M | 554.50%9.34M | -310.06%-4.22M | 80.61%-2.06M | 119.73%2.01M | -484.67%-10.6M | -3,092.35%-10.17M | -323.55%-1.81M |
Accounts payable increase (decrease) | -136.37%-423K | 46.39%1.84M | -61.26%1.16M | 46.57%1.26M | 16.95%3M | 110.30%859K | -0.12%2.57M | -1,640.29%-8.34M | 192.48%2.57M | -27.73%-479K |
Cash from business operations | -18.86%14.39M | 226.71%40.32M | 335.74%17.74M | -48.30%12.34M | -307.25%-7.52M | 491.76%23.87M | 165.80%3.63M | -123.86%-6.09M | -181.28%-5.52M | -15.97%25.54M |
Other taxs | 6.13%-3.17M | -25.99%-8.64M | -58.13%-3.38M | -100.67%-6.86M | -35.13%-2.14M | 35.71%-3.42M | 29.72%-1.58M | 14.18%-5.32M | 16.74%-2.25M | 13.82%-6.19M |
Interest paid - operating | -24.14%-36K | 21.95%-64K | 19.44%-29K | -30.16%-82K | -44.00%-36K | 26.74%-63K | 37.50%-25K | 67.05%-86K | 78.14%-40K | -75.17%-261K |
Net cash from operations | -21.94%11.19M | 485.23%31.62M | 247.82%14.33M | -73.51%5.4M | -578.72%-9.69M | 277.42%20.39M | 125.94%2.03M | -160.24%-11.5M | -299.87%-7.81M | -17.23%19.08M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 53.85%1.1M | 61.85%1.87M | 126.98%715K | 12.78%1.16M | -50.47%315K | 1,165.43%1.03M | 1,100.00%636K | 37.29%81K | 65.63%53K | -60.14%59K |
Decrease in deposits (increase) | --102K | ---102K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | --348K | ---- | ---- | ---- | ---- | 35.53%103K | --95K | -66.07%76K | ---- | -51.41%224K |
Purchase of fixed assets | 95.55%-657K | -908.71%-16.56M | -2,194.25%-14.75M | -51.06%-1.64M | -1,239.58%-643K | -23.10%-1.09M | 87.43%-48K | 36.43%-883K | -21.27%-382K | -109.82%-1.39M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---1.55M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 49.70%750K | 420.83%750K | -91.03%501K | -96.99%144K | 1,886.83%5.58M | --4.78M | --281K | ---- | ---- |
Cash on investment | ---5M | 52.80%-2.98M | ---- | 14.19%-6.32M | -6.73%-5.52M | -24.12%-7.37M | ---5.17M | ---5.93M | ---- | ---- |
Net cash from investment operations | 69.09%-4.11M | -170.06%-17.03M | -133.11%-13.29M | -91.41%-6.31M | -2,019.19%-5.7M | 48.36%-3.29M | 190.27%297K | -476.76%-6.38M | -58.94%-329K | 15.77%-1.11M |
Net cash before financing | 578.72%7.08M | 1,717.85%14.59M | 106.78%1.04M | -105.27%-902K | -762.96%-15.39M | 195.67%17.1M | 128.55%2.32M | -199.43%-17.87M | -319.96%-8.13M | -17.32%17.98M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 247.56%1.14M | -16.44%910K | 0.00%328K | 683.45%1.09M | -3.24%328K | -30.50%139K | -55.39%339K | -51.34%200K | -85.67%760K |
Refund | 71.14%-357K | -43.47%-2.68M | 11.33%-1.24M | 20.65%-1.87M | -24.00%-1.4M | -79.69%-2.35M | -121.46%-1.13M | 85.89%-1.31M | 93.35%-508K | 71.80%-9.28M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --67.58M | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---18.66M | ---- | ---- |
Net cash from financing operations | -5.53%-802K | 0.00%-1.54M | -21.02%-760K | 23.99%-1.54M | 50.36%-628K | -104.27%-2.03M | -110.48%-1.27M | 621.82%47.39M | 92.00%-601K | 69.50%-9.08M |
Effect of rate | 1.76%753K | 122.53%1.04M | 69.34%740K | 2,841.18%466K | 2,470.59%437K | -206.25%-17K | 6.25%17K | 500.00%16K | 161.54%16K | -102.45%-4K |
Net Cash | 2,118.02%6.28M | 634.52%13.05M | 101.77%283K | -116.20%-2.44M | -1,615.80%-16.02M | -48.93%15.07M | 112.10%1.06M | 231.85%29.52M | -129.02%-8.74M | 210.68%8.9M |
Begining period cash | 17.80%93.25M | -2.44%79.16M | -2.44%79.16M | 22.79%81.13M | 22.79%81.13M | 80.82%66.08M | 80.82%66.08M | 32.16%36.54M | 32.16%36.54M | -22.17%27.65M |
Cash at the end | 25.07%100.28M | 17.80%93.25M | 22.32%80.18M | -2.44%79.16M | -2.39%65.55M | 22.79%81.13M | 141.35%67.15M | 80.82%66.08M | 16.85%27.82M | 32.16%36.54M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16.85%27.82M | ---- |
Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Forvis Mazars LLP, Forvis Mazars LLP | -- | Forvis Mazars LLP, Forvis Mazars LLP | -- | Forvis Mazars LLP, Forvis Mazars LLP | -- | Forvis Mazars LLP, Forvis Mazars LLP | -- | Forvis Mazars LLP, Forvis Mazars LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data